Harpreet S Bajaj, Itamar Raz, Ofri Mosenzon, Sabina A Murphy, Aliza Rozenberg, Ilan Yanuv, Deepak L Bhatt, Lawrence A Leiter, Darren K McGuire, John P H Wilding, Ingrid A M Gause-Nilsson, Marc S Sabatine, Stephen D Wiviott, Avivit Cahn. Diabetes Obes Metab 2020
Times Cited: 5
Times Cited: 5
Times Cited
Times Co-cited
Similarity
Dapagliflozin and Cardiovascular Outcomes in Type 2 Diabetes.
Stephen D Wiviott, Itamar Raz, Marc P Bonaca, Ofri Mosenzon, Eri T Kato, Avivit Cahn, Michael G Silverman, Thomas A Zelniker, Julia F Kuder, Sabina A Murphy,[...]. N Engl J Med 2019
Stephen D Wiviott, Itamar Raz, Marc P Bonaca, Ofri Mosenzon, Eri T Kato, Avivit Cahn, Michael G Silverman, Thomas A Zelniker, Julia F Kuder, Sabina A Murphy,[...]. N Engl J Med 2019
80
Dapagliflozin and Cardiovascular Outcomes in Patients With Type 2 Diabetes Mellitus and Previous Myocardial Infarction.
Remo H M Furtado, Marc P Bonaca, Itamar Raz, Thomas A Zelniker, Ofri Mosenzon, Avivit Cahn, Julia Kuder, Sabina A Murphy, Deepak L Bhatt, Lawrence A Leiter,[...]. Circulation 2019
Remo H M Furtado, Marc P Bonaca, Itamar Raz, Thomas A Zelniker, Ofri Mosenzon, Avivit Cahn, Julia Kuder, Sabina A Murphy, Deepak L Bhatt, Lawrence A Leiter,[...]. Circulation 2019
60
Saxagliptin and cardiovascular outcomes in patients with type 2 diabetes mellitus.
Benjamin M Scirica, Deepak L Bhatt, Eugene Braunwald, P Gabriel Steg, Jaime Davidson, Boaz Hirshberg, Peter Ohman, Robert Frederich, Stephen D Wiviott, Elaine B Hoffman,[...]. N Engl J Med 2013
Benjamin M Scirica, Deepak L Bhatt, Eugene Braunwald, P Gabriel Steg, Jaime Davidson, Boaz Hirshberg, Peter Ohman, Robert Frederich, Stephen D Wiviott, Elaine B Hoffman,[...]. N Engl J Med 2013
60
Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction.
John J V McMurray, Scott D Solomon, Silvio E Inzucchi, Lars Køber, Mikhail N Kosiborod, Felipe A Martinez, Piotr Ponikowski, Marc S Sabatine, Inder S Anand, Jan Bělohlávek,[...]. N Engl J Med 2019
John J V McMurray, Scott D Solomon, Silvio E Inzucchi, Lars Køber, Mikhail N Kosiborod, Felipe A Martinez, Piotr Ponikowski, Marc S Sabatine, Inder S Anand, Jan Bělohlávek,[...]. N Engl J Med 2019
60
Mechanisms of Cardiorenal Effects of Sodium-Glucose Cotransporter 2 Inhibitors: JACC State-of-the-Art Review.
Thomas A Zelniker, Eugene Braunwald. J Am Coll Cardiol 2020
Thomas A Zelniker, Eugene Braunwald. J Am Coll Cardiol 2020
40
Dapagliflozin is associated with lower risk of cardiovascular events and all-cause mortality in people with type 2 diabetes (CVD-REAL Nordic) when compared with dipeptidyl peptidase-4 inhibitor therapy: A multinational observational study.
Frederik Persson, Thomas Nyström, Marit E Jørgensen, Bendix Carstensen, Hanne L Gulseth, Marcus Thuresson, Peter Fenici, David Nathanson, Jan W Eriksson, Anna Norhammar,[...]. Diabetes Obes Metab 2018
Frederik Persson, Thomas Nyström, Marit E Jørgensen, Bendix Carstensen, Hanne L Gulseth, Marcus Thuresson, Peter Fenici, David Nathanson, Jan W Eriksson, Anna Norhammar,[...]. Diabetes Obes Metab 2018
40
Effect of Dapagliflozin on Heart Failure and Mortality in Type 2 Diabetes Mellitus.
Eri T Kato, Michael G Silverman, Ofri Mosenzon, Thomas A Zelniker, Avivit Cahn, Remo H M Furtado, Julia Kuder, Sabina A Murphy, Deepak L Bhatt, Lawrence A Leiter,[...]. Circulation 2019
Eri T Kato, Michael G Silverman, Ofri Mosenzon, Thomas A Zelniker, Avivit Cahn, Remo H M Furtado, Julia Kuder, Sabina A Murphy, Deepak L Bhatt, Lawrence A Leiter,[...]. Circulation 2019
40
Cardiovascular Events Associated With SGLT-2 Inhibitors Versus Other Glucose-Lowering Drugs: The CVD-REAL 2 Study.
Mikhail Kosiborod, Carolyn S P Lam, Shun Kohsaka, Dae Jung Kim, Avraham Karasik, Jonathan Shaw, Navdeep Tangri, Su-Yen Goh, Marcus Thuresson, Hungta Chen,[...]. J Am Coll Cardiol 2018
Mikhail Kosiborod, Carolyn S P Lam, Shun Kohsaka, Dae Jung Kim, Avraham Karasik, Jonathan Shaw, Navdeep Tangri, Su-Yen Goh, Marcus Thuresson, Hungta Chen,[...]. J Am Coll Cardiol 2018
40
Risk Factors, Mortality, and Cardiovascular Outcomes in Patients with Type 2 Diabetes.
Aidin Rawshani, Araz Rawshani, Stefan Franzén, Naveed Sattar, Björn Eliasson, Ann-Marie Svensson, Björn Zethelius, Mervete Miftaraj, Darren K McGuire, Annika Rosengren,[...]. N Engl J Med 2018
Aidin Rawshani, Araz Rawshani, Stefan Franzén, Naveed Sattar, Björn Eliasson, Ann-Marie Svensson, Björn Zethelius, Mervete Miftaraj, Darren K McGuire, Annika Rosengren,[...]. N Engl J Med 2018
40
Alogliptin after acute coronary syndrome in patients with type 2 diabetes.
William B White, Christopher P Cannon, Simon R Heller, Steven E Nissen, Richard M Bergenstal, George L Bakris, Alfonso T Perez, Penny R Fleck, Cyrus R Mehta, Stuart Kupfer,[...]. N Engl J Med 2013
William B White, Christopher P Cannon, Simon R Heller, Steven E Nissen, Richard M Bergenstal, George L Bakris, Alfonso T Perez, Penny R Fleck, Cyrus R Mehta, Stuart Kupfer,[...]. N Engl J Med 2013
40
Lower Risk of Heart Failure and Death in Patients Initiated on Sodium-Glucose Cotransporter-2 Inhibitors Versus Other Glucose-Lowering Drugs: The CVD-REAL Study (Comparative Effectiveness of Cardiovascular Outcomes in New Users of Sodium-Glucose Cotransporter-2 Inhibitors).
Mikhail Kosiborod, Matthew A Cavender, Alex Z Fu, John P Wilding, Kamlesh Khunti, Reinhard W Holl, Anna Norhammar, Kåre I Birkeland, Marit Eika Jørgensen, Marcus Thuresson,[...]. Circulation 2017
Mikhail Kosiborod, Matthew A Cavender, Alex Z Fu, John P Wilding, Kamlesh Khunti, Reinhard W Holl, Anna Norhammar, Kåre I Birkeland, Marit Eika Jørgensen, Marcus Thuresson,[...]. Circulation 2017
40
Effect of Sitagliptin on Cardiovascular Outcomes in Type 2 Diabetes.
Jennifer B Green, M Angelyn Bethel, Paul W Armstrong, John B Buse, Samuel S Engel, Jyotsna Garg, Robert Josse, Keith D Kaufman, Joerg Koglin, Scott Korn,[...]. N Engl J Med 2015
Jennifer B Green, M Angelyn Bethel, Paul W Armstrong, John B Buse, Samuel S Engel, Jyotsna Garg, Robert Josse, Keith D Kaufman, Joerg Koglin, Scott Korn,[...]. N Engl J Med 2015
40
Effect of Linagliptin vs Placebo on Major Cardiovascular Events in Adults With Type 2 Diabetes and High Cardiovascular and Renal Risk: The CARMELINA Randomized Clinical Trial.
Julio Rosenstock, Vlado Perkovic, Odd Erik Johansen, Mark E Cooper, Steven E Kahn, Nikolaus Marx, John H Alexander, Michael Pencina, Robert D Toto, Christoph Wanner,[...]. JAMA 2019
Julio Rosenstock, Vlado Perkovic, Odd Erik Johansen, Mark E Cooper, Steven E Kahn, Nikolaus Marx, John H Alexander, Michael Pencina, Robert D Toto, Christoph Wanner,[...]. JAMA 2019
40
Effects of dapagliflozin on development and progression of kidney disease in patients with type 2 diabetes: an analysis from the DECLARE-TIMI 58 randomised trial.
Ofri Mosenzon, Stephen D Wiviott, Avivit Cahn, Aliza Rozenberg, Ilan Yanuv, Erica L Goodrich, Sabina A Murphy, Hiddo J L Heerspink, Thomas A Zelniker, Jamie P Dwyer,[...]. Lancet Diabetes Endocrinol 2019
Ofri Mosenzon, Stephen D Wiviott, Avivit Cahn, Aliza Rozenberg, Ilan Yanuv, Erica L Goodrich, Sabina A Murphy, Hiddo J L Heerspink, Thomas A Zelniker, Jamie P Dwyer,[...]. Lancet Diabetes Endocrinol 2019
40
Cardiovascular mortality and morbidity in patients with type 2 diabetes following initiation of sodium-glucose co-transporter-2 inhibitors versus other glucose-lowering drugs (CVD-REAL Nordic): a multinational observational analysis.
Kåre I Birkeland, Marit E Jørgensen, Bendix Carstensen, Frederik Persson, Hanne L Gulseth, Marcus Thuresson, Peter Fenici, David Nathanson, Thomas Nyström, Jan W Eriksson,[...]. Lancet Diabetes Endocrinol 2017
Kåre I Birkeland, Marit E Jørgensen, Bendix Carstensen, Frederik Persson, Hanne L Gulseth, Marcus Thuresson, Peter Fenici, David Nathanson, Thomas Nyström, Jan W Eriksson,[...]. Lancet Diabetes Endocrinol 2017
40
Renal, metabolic and cardiovascular considerations of SGLT2 inhibition.
Ralph A DeFronzo, Luke Norton, Muhammad Abdul-Ghani. Nat Rev Nephrol 2017
Ralph A DeFronzo, Luke Norton, Muhammad Abdul-Ghani. Nat Rev Nephrol 2017
40
Canagliflozin and Cardiovascular and Renal Events in Type 2 Diabetes.
Bruce Neal, Vlado Perkovic, Kenneth W Mahaffey, Dick de Zeeuw, Greg Fulcher, Ngozi Erondu, Wayne Shaw, Gordon Law, Mehul Desai, David R Matthews. N Engl J Med 2017
Bruce Neal, Vlado Perkovic, Kenneth W Mahaffey, Dick de Zeeuw, Greg Fulcher, Ngozi Erondu, Wayne Shaw, Gordon Law, Mehul Desai, David R Matthews. N Engl J Med 2017
40
Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes.
Bernard Zinman, Christoph Wanner, John M Lachin, David Fitchett, Erich Bluhmki, Stefan Hantel, Michaela Mattheus, Theresa Devins, Odd Erik Johansen, Hans J Woerle,[...]. N Engl J Med 2015
Bernard Zinman, Christoph Wanner, John M Lachin, David Fitchett, Erich Bluhmki, Stefan Hantel, Michaela Mattheus, Theresa Devins, Odd Erik Johansen, Hans J Woerle,[...]. N Engl J Med 2015
40
SGLT2 inhibitors for primary and secondary prevention of cardiovascular and renal outcomes in type 2 diabetes: a systematic review and meta-analysis of cardiovascular outcome trials.
Thomas A Zelniker, Stephen D Wiviott, Itamar Raz, Kyungah Im, Erica L Goodrich, Marc P Bonaca, Ofri Mosenzon, Eri T Kato, Avivit Cahn, Remo H M Furtado,[...]. Lancet 2019
Thomas A Zelniker, Stephen D Wiviott, Itamar Raz, Kyungah Im, Erica L Goodrich, Marc P Bonaca, Ofri Mosenzon, Eri T Kato, Avivit Cahn, Remo H M Furtado,[...]. Lancet 2019
40
Haptoglobin Phenotype Modifies the Influence of Intensive Glycemic Control on Cardiovascular Outcomes.
Allie S Carew, Andrew P Levy, Henry N Ginsberg, Steven Coca, Orit Lache, Thomas Ransom, Robert Byington, Eric B Rimm, John Sapp, Martin Gardner,[...]. J Am Coll Cardiol 2020
Allie S Carew, Andrew P Levy, Henry N Ginsberg, Steven Coca, Orit Lache, Thomas Ransom, Robert Byington, Eric B Rimm, John Sapp, Martin Gardner,[...]. J Am Coll Cardiol 2020
20
Comparison of Cardiovascular and Safety Outcomes of Chlorthalidone vs Hydrochlorothiazide to Treat Hypertension.
George Hripcsak, Marc A Suchard, Steven Shea, RuiJun Chen, Seng Chan You, Nicole Pratt, David Madigan, Harlan M Krumholz, Patrick B Ryan, Martijn J Schuemie. JAMA Intern Med 2020
George Hripcsak, Marc A Suchard, Steven Shea, RuiJun Chen, Seng Chan You, Nicole Pratt, David Madigan, Harlan M Krumholz, Patrick B Ryan, Martijn J Schuemie. JAMA Intern Med 2020
20
Combined randomised controlled trial experience of malignancies in studies using insulin glargine.
P D Home, P Lagarenne. Diabetologia 2009
P D Home, P Lagarenne. Diabetologia 2009
20
Association Between Renin-Angiotensin System Blockade Discontinuation and All-Cause Mortality Among Persons With Low Estimated Glomerular Filtration Rate.
Yao Qiao, Jung-Im Shin, Teresa K Chen, Lesley A Inker, Josef Coresh, G Caleb Alexander, John W Jackson, Alex R Chang, Morgan E Grams. JAMA Intern Med 2020
Yao Qiao, Jung-Im Shin, Teresa K Chen, Lesley A Inker, Josef Coresh, G Caleb Alexander, John W Jackson, Alex R Chang, Morgan E Grams. JAMA Intern Med 2020
20
Effects of Intensive Versus Standard Ambulatory Blood Pressure Control on Cerebrovascular Outcomes in Older People (INFINITY).
William B White, Dorothy B Wakefield, Nicola Moscufo, Charles R G Guttmann, Richard F Kaplan, Richard W Bohannon, Douglas Fellows, Charles B Hall, Leslie Wolfson. Circulation 2019
William B White, Dorothy B Wakefield, Nicola Moscufo, Charles R G Guttmann, Richard F Kaplan, Richard W Bohannon, Douglas Fellows, Charles B Hall, Leslie Wolfson. Circulation 2019
20
Effect of Acupuncture vs Sham Procedure on Chemotherapy-Induced Peripheral Neuropathy Symptoms: A Randomized Clinical Trial.
Ting Bao, Sujata Patil, Connie Chen, Iris W Zhi, Qing S Li, Lauren Piulson, Jun J Mao. JAMA Netw Open 2020
Ting Bao, Sujata Patil, Connie Chen, Iris W Zhi, Qing S Li, Lauren Piulson, Jun J Mao. JAMA Netw Open 2020
20
Similar Breast Cancer Risk in Women Older Than 65 Years Initiating Glargine, Detemir, and NPH Insulins.
Marie C Bradley, Yoganand Chillarige, Hana Lee, Xiyuan Wu, Shruti Parulekar, Michael Wernecke, Patricia Bright, Mat Soukup, Thomas E MaCurdy, Jeffrey A Kelman,[...]. Diabetes Care 2020
Marie C Bradley, Yoganand Chillarige, Hana Lee, Xiyuan Wu, Shruti Parulekar, Michael Wernecke, Patricia Bright, Mat Soukup, Thomas E MaCurdy, Jeffrey A Kelman,[...]. Diabetes Care 2020
50
The influence of glucose-lowering therapies on cancer risk in type 2 diabetes.
C J Currie, C D Poole, E A M Gale. Diabetologia 2009
C J Currie, C D Poole, E A M Gale. Diabetologia 2009
20
Interindividual Heterogeneity of SGLT2 Expression and Function in Human Pancreatic Islets.
Chiara Saponaro, Markus Mühlemann, Ana Acosta-Montalvo, Anthony Piron, Valery Gmyr, Nathalie Delalleau, Ericka Moerman, Julien Thévenet, Gianni Pasquetti, Anais Coddeville,[...]. Diabetes 2020
Chiara Saponaro, Markus Mühlemann, Ana Acosta-Montalvo, Anthony Piron, Valery Gmyr, Nathalie Delalleau, Ericka Moerman, Julien Thévenet, Gianni Pasquetti, Anais Coddeville,[...]. Diabetes 2020
20
Blood pressure and glucose control and the prevalence of albuminuria and left ventricular hypertrophy in patients with hypertension and diabetes.
Wei Zhang, Chang-Yuan Liu, Li-Nong Ji, Ji-Guang Wang. J Clin Hypertens (Greenwich) 2020
Wei Zhang, Chang-Yuan Liu, Li-Nong Ji, Ji-Guang Wang. J Clin Hypertens (Greenwich) 2020
33
ACE and Type 2 Diabetes Risk: A Mendelian Randomization Study.
Marie Pigeyre, Jennifer Sjaarda, Michael Chong, Sibylle Hess, Jackie Bosch, Salim Yusuf, Hertzel Gerstein, Guillaume Paré. Diabetes Care 2020
Marie Pigeyre, Jennifer Sjaarda, Michael Chong, Sibylle Hess, Jackie Bosch, Salim Yusuf, Hertzel Gerstein, Guillaume Paré. Diabetes Care 2020
20
Risk of Cirrhosis and Hepatocellular Cancer in Patients With NAFLD and Normal Liver Enzymes.
Yamini Natarajan, Jennifer R Kramer, Xian Yu, Liang Li, Aaron P Thrift, Hashem B El-Serag, Fasiha Kanwal. Hepatology 2020
Yamini Natarajan, Jennifer R Kramer, Xian Yu, Liang Li, Aaron P Thrift, Hashem B El-Serag, Fasiha Kanwal. Hepatology 2020
20
Associations of serum magnesium levels and calcium-magnesium ratios with mortality in patients with coronary artery disease.
Q Li, Q Chen, H Zhang, Z Xu, X Wang, J Pang, J Ma, W Ling, D Li. Diabetes Metab 2020
Q Li, Q Chen, H Zhang, Z Xu, X Wang, J Pang, J Ma, W Ling, D Li. Diabetes Metab 2020
100
Follicle-stimulating hormone and estradiol are associated with bone mineral density and risk of fractures in men with type 2 diabetes mellitus.
Yixuan Jing, Xiaofeng Wang, Jingjia Yu, Xiaojing Wang, Yanman Zhou, Bei Tao, Lihao Sun, Jianmin Liu, Hongyan Zhao. J Diabetes 2020
Yixuan Jing, Xiaofeng Wang, Jingjia Yu, Xiaojing Wang, Yanman Zhou, Bei Tao, Lihao Sun, Jianmin Liu, Hongyan Zhao. J Diabetes 2020
100
Use of insulin glargine and cancer incidence in Scotland: a study from the Scottish Diabetes Research Network Epidemiology Group.
H M Colhoun. Diabetologia 2009
H M Colhoun. Diabetologia 2009
20
The importance of hyperosmolarity in diabetic ketoacidosis.
S P Blank, R M Blank, M D Ziegenfuss. Diabet Med 2020
S P Blank, R M Blank, M D Ziegenfuss. Diabet Med 2020
100
Chronic Kidney Disease, Diabetes, and Risk of Mortality After Acute Myocardial Infarction: Insight From the FAST-MI Program.
Louis Potier, Ronan Roussel, Marianne Zeller, François Schiele, Etienne Puymirat, Tabassome Simon, Nicolas Danchin. Diabetes Care 2020
Louis Potier, Ronan Roussel, Marianne Zeller, François Schiele, Etienne Puymirat, Tabassome Simon, Nicolas Danchin. Diabetes Care 2020
50
PPARA Polymorphism Influences the Cardiovascular Benefit of Fenofibrate in Type 2 Diabetes: Findings From ACCORD-Lipid.
Mario Luca Morieri, Hetal S Shah, Jennifer Sjaarda, Petra A Lenzini, Hannah Campbell, Alison A Motsinger-Reif, He Gao, Laura Lovato, Sabrina Prudente, Assunta Pandolfi,[...]. Diabetes 2020
Mario Luca Morieri, Hetal S Shah, Jennifer Sjaarda, Petra A Lenzini, Hannah Campbell, Alison A Motsinger-Reif, He Gao, Laura Lovato, Sabrina Prudente, Assunta Pandolfi,[...]. Diabetes 2020
33
Cardiovascular outcomes with sodium-glucose cotransporter-2 inhibitors in patients with type II diabetes mellitus: A meta-analysis of placebo-controlled randomized trials.
Marwan Saad, Ahmed N Mahmoud, Islam Y Elgendy, Ahmed Abuzaid, Amr F Barakat, Akram Y Elgendy, Mohammad Al-Ani, Amgad Mentias, Ramez Nairooz, Anthony A Bavry,[...]. Int J Cardiol 2017
Marwan Saad, Ahmed N Mahmoud, Islam Y Elgendy, Ahmed Abuzaid, Amr F Barakat, Akram Y Elgendy, Mohammad Al-Ani, Amgad Mentias, Ramez Nairooz, Anthony A Bavry,[...]. Int J Cardiol 2017
20
Correction of hyperglycemia with phlorizin normalizes tissue sensitivity to insulin in diabetic rats.
L Rossetti, D Smith, G I Shulman, D Papachristou, R A DeFronzo. J Clin Invest 1987
L Rossetti, D Smith, G I Shulman, D Papachristou, R A DeFronzo. J Clin Invest 1987
20
Cardiovascular safety of anti-diabetic drugs.
R Kumar, D M Kerins, T Walther. Eur Heart J Cardiovasc Pharmacother 2016
R Kumar, D M Kerins, T Walther. Eur Heart J Cardiovasc Pharmacother 2016
20
Effects of the SGLT2 inhibitor dapagliflozin on HDL cholesterol, particle size, and cholesterol efflux capacity in patients with type 2 diabetes: a randomized placebo-controlled trial.
Gian Paolo Fadini, Benedetta Maria Bonora, Giancarlo Zatti, Nicola Vitturi, Elisabetta Iori, Maria Cristina Marescotti, Mattia Albiero, Angelo Avogaro. Cardiovasc Diabetol 2017
Gian Paolo Fadini, Benedetta Maria Bonora, Giancarlo Zatti, Nicola Vitturi, Elisabetta Iori, Maria Cristina Marescotti, Mattia Albiero, Angelo Avogaro. Cardiovasc Diabetol 2017
20
Sitagliptin use in patients with diabetes and heart failure: a population-based retrospective cohort study.
Daniala L Weir, Finlay A McAlister, Ambikaipakan Senthilselvan, Jasjeet K Minhas-Sandhu, Dean T Eurich. JACC Heart Fail 2014
Daniala L Weir, Finlay A McAlister, Ambikaipakan Senthilselvan, Jasjeet K Minhas-Sandhu, Dean T Eurich. JACC Heart Fail 2014
20
The beneficial effects of empagliflozin, an SGLT2 inhibitor, on atherosclerosis in ApoE -/- mice fed a western diet.
Ji Hye Han, Tae Jung Oh, Ghayoung Lee, Hyo Jin Maeng, Dong Hwa Lee, Kyoung Min Kim, Sung Hee Choi, Hak Chul Jang, Hye Seung Lee, Kyong Soo Park,[...]. Diabetologia 2017
Ji Hye Han, Tae Jung Oh, Ghayoung Lee, Hyo Jin Maeng, Dong Hwa Lee, Kyoung Min Kim, Sung Hee Choi, Hak Chul Jang, Hye Seung Lee, Kyong Soo Park,[...]. Diabetologia 2017
20
DPP-4 inhibitors and lipids: systematic review and meta-analysis.
Matteo Monami, Caterina Lamanna, Carla Maria Desideri, Edoardo Mannucci. Adv Ther 2012
Matteo Monami, Caterina Lamanna, Carla Maria Desideri, Edoardo Mannucci. Adv Ther 2012
20
Cardiovascular Outcomes With the Use of Sodium-Glucose Cotransporter-2 Inhibitors in Patients With Type 2 Diabetes and Chronic Kidney Disease: An Updated Meta-Analysis of Randomized Controlled Trials.
Aaqib H Malik, Srikanth Yandrapalli, Michael Goldberg, Diwakar Jain, William H Frishman, Wilbert S Aronow. Cardiol Rev 2020
Aaqib H Malik, Srikanth Yandrapalli, Michael Goldberg, Diwakar Jain, William H Frishman, Wilbert S Aronow. Cardiol Rev 2020
33
Heart failure, saxagliptin, and diabetes mellitus: observations from the SAVOR-TIMI 53 randomized trial.
Benjamin M Scirica, Eugene Braunwald, Itamar Raz, Matthew A Cavender, David A Morrow, Petr Jarolim, Jacob A Udell, Ofri Mosenzon, KyungAh Im, Amarachi A Umez-Eronini,[...]. Circulation 2014
Benjamin M Scirica, Eugene Braunwald, Itamar Raz, Matthew A Cavender, David A Morrow, Petr Jarolim, Jacob A Udell, Ofri Mosenzon, KyungAh Im, Amarachi A Umez-Eronini,[...]. Circulation 2014
20
Cardiovascular Actions and Clinical Outcomes With Glucagon-Like Peptide-1 Receptor Agonists and Dipeptidyl Peptidase-4 Inhibitors.
Michael A Nauck, Juris J Meier, Matthew A Cavender, Mirna Abd El Aziz, Daniel J Drucker. Circulation 2017
Michael A Nauck, Juris J Meier, Matthew A Cavender, Mirna Abd El Aziz, Daniel J Drucker. Circulation 2017
20
Effect of Dapagliflozin on Glycemic Control, Weight, and Blood Pressure in Patients with Type 2 Diabetes Attending a Specialist Endocrinology Practice in Canada: A Retrospective Cohort Analysis.
Ruth E Brown, Nikhil Gupta, Ronnie Aronson. Diabetes Technol Ther 2017
Ruth E Brown, Nikhil Gupta, Ronnie Aronson. Diabetes Technol Ther 2017
20
Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.